Education
About Us
Working with TipRanks
Follow Us
Kobayashi Pharmaceutical Co Ltd (JP:4967)
:4967
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 165.74B | ¥ 165.60B | ¥ 173.46B | ¥ 166.26B | ¥ 155.25B |
| Gross Profit | ¥ 79.44B | ¥ 87.60B | ¥ 96.38B | ¥ 92.33B | ¥ 88.77B |
| Operating Income | ¥ 14.85B | ¥ 24.86B | ¥ 25.78B | ¥ 26.67B | ¥ 26.07B |
| EBITDA | ¥ 23.59B | ¥ 21.96B | ¥ 33.65B | ¥ 33.33B | ¥ 32.49B |
| Net Income | ¥ 3.66B | ¥ 10.07B | ¥ 20.34B | ¥ 20.02B | ¥ 19.71B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 70.61B | ¥ 65.75B | ¥ 79.84B | ¥ 104.53B | ¥ 109.05B |
| Total Assets | ¥ 275.33B | ¥ 265.37B | ¥ 267.47B | ¥ 255.83B | ¥ 252.55B |
| Total Debt | ¥ 678.00M | ¥ 846.00M | ¥ 987.00M | ¥ 792.00M | ¥ 630.00M |
| Net Debt | ¥ -61.64B | ¥ -50.03B | ¥ -70.55B | ¥ -95.44B | ¥ -94.39B |
| Total Liabilities | ¥ 64.32B | ¥ 51.90B | ¥ 62.66B | ¥ 57.93B | ¥ 56.95B |
| Stockholders' Equity | ¥ 211.00B | ¥ 213.47B | ¥ 204.82B | ¥ 197.90B | ¥ 195.60B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 12.34B | ¥ -14.81B | ¥ 4.79B | ¥ 15.69B | ¥ 18.23B |
| Operating Cash Flow | ¥ 25.59B | ¥ 11.25B | ¥ 18.36B | ¥ 31.91B | ¥ 22.42B |
| Investing Cash Flow | ¥ -154.00M | ¥ -18.41B | ¥ -19.58B | ¥ -14.31B | ¥ 7.99B |
| Financing Cash Flow | ¥ -7.92B | ¥ -7.77B | ¥ -19.46B | ¥ -20.76B | ¥ -10.38B |